← Back
Data updated: Mar 10, 2026
PHARMAAND
Oncology
PHARMAAND is a pharmaceutical company focused on Oncology. Key products include RUBRACA.
2016
Since
1
Drugs
-
Trials
2
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 4 Phase 2: 5 Phase 1: 7
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2016-12-19
- Latest
- 2025-12-17
- Applications
- 1